Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Trujillo JA, Godfrey J, Hu Y, Huang J, Smith SM, Frigault MJ, DeFilipp Z, Appelbaum D, Pu Y, Feinberg N, Althaus T, Bishop MR, Riedell PA, Kline J.
Trujillo JA, et al. Among authors: appelbaum d.
Blood. 2021 Jun 17;137(24):3454-3459. doi: 10.1182/blood.2020009148.
Blood. 2021.
PMID: 33881502
Free PMC article.
No abstract available.